Keith J. Kendall, CEO and President at Aquestive Therapeutics, Inc. (AQST), bought 7,950 shares at $10.17 ($80K) on 2018-11-21, disclosed to the SEC on 2018-11-26.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.17 | 6,000 | $61K | 76.0% |
| 2 | $9.90 | 1,950 | $19K | 24.0% |
| Total | $10.10 avg | 7,950 | $80K | 100% |
| Filing → |
| AQST | BUY | 2018-11-28 | $10K | — | Filing → |